The Newest Way to
Master Your Health

Few things in life are as democratic as aging. But it's not exactly the type of democracy that empowers us, bringing peace and prosperity with it. Instead, we're each passed a slightly different set of genetic material from our parents which informs our height, eye color, and yes, predispositions for health. And while some of us get dealt a better genetic hand than others, we'll all experience the natural decline of health that comes with time. Traditionally, our understanding has been that eating a healthy diet and exercising regularly were our only levers to support long-term well-being.

That's all changing. Scientists are beginning to understand the causes of aging, and in the foreseeable future you'll begin seeing drugs, therapies, and natural products meant to target the causes of aging at the cellular level. Ever heard of metformin, rapamycin, or senotherapeutics? If not, you will soon.

One company, Elysium Health, a New York-based startup founded by the head of the Science of Aging Lab at M.I.T., Dr. Leonard Guarente, is bringing these advances in aging research directly to consumers. Elysium counts some of the most accomplished scientists in the world among its scientific advisory board, and Guarente is best known for his research on the role of sirtuins, a family of proteins that control the body's response to stress and aging. That research is the foundation for Basis, Elysium's first product: a supplement containing two ingredients, nicotinamide riboside and pterostilbene, intended to support the long-term health of human cells.

Basis is designed to help cells stay healthy in two ways. The first is by supporting sirtuin activity; the other is by increasing natural supplies of a coenzyme (also known as a "helper molecule") called NAD+ that's essential to many of the fundamental processes in our cells. Sirtuins require NAD+ to work, and both are essential for mitochondrial function (how we produce energy from food), liver health, and maintaining the integrity of your DNA, among other things. And NAD+ declines in all organisms, including humans, as we age.

This is where Basis comes in.

In Elysium's recent clinical trial, the first study of its kind in humans, participants who took the recommended dose of Basis saw their NAD+ levels increase 40 percent within a month and remain at that level for the duration of the eight-week trial. Of course, Elysium isn't making claims about stopping or reversing the aging process, but their continued efforts to find ways to support and maintain healthy cellular function offer another level--on top of diet and exercise--to help you stay in peak condition. That sounds like an improvement to the democratic process to us.

Learn more about Elysium's Basis »